The Worldwide Oxidative Stress Assay Industry is Projected to Reach $1.3 Billion by 2025 at a CAGR of 9.7% from 2020

News provided by

Apr 29, 2021, 09:45 ET

DUBLIN, April 29, 2021 /PRNewswire/ -- The "Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, Nucleic Acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.

The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%.

Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.

The consumables segment accounted for the largest market share in 2020.

Based on products, the oxidative stress assay market is segmented into consumables, instruments, and software and services. Consumables is the largest and fastest-growing segment in 2020. This large share and high growth can be attributed the recurring requirement of consumables as compared to instruments which is the key factor driving the growth of this segment.

The cardiovascular diseases segment will continue to dominate the oxidative stress assay market during the forecast period.

Based on disease type, the oxidative stress assays market is segmented into cardiovascular diseases, diabetes, cancer, respiratory diseases, and other diseases. The cardiovascular diseases segment accounted for the largest share of this market in 2020, primarily due to the high and growing prevalence of cardiovascular diseases across the globe.

The oxidative stress assay market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.

Geographically, the oxidative stress assay market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the reason that the Asia Pacific oxidative stress assays market offers significant growth opportunities for market players to expand their presence in this region. Emerging markets such as China and India are witnessing growth due to the large patient population and increasing healthcare expenditure. This has resulted in the increasing acceptance of advanced technologies, such as oxidative stress assays, in the Asia Pacific region.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Oxidative Stress Assays Market Overview
4.2 North America: Oxidative Stress Assay Consumables Market (2020)
4.3 Oxidative Stress Assays Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rapid Growth in the Biopharmaceutical and Biotechnology Industries
5.2.1.2 Growing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industries
5.2.1.3 Technological Advancements Such as High-Content Screening for Drug Discovery
5.2.1.4 Government Funding for Life Science Research
5.2.1.5 Emergence of Label-Free Detection Technologies
5.2.2 Restraints
5.2.2.1 High Cost of Instruments
5.2.2.2 Shortage of Trained Personnel for New and Emerging Technologies
5.2.3 Opportunities
5.2.3.1 Emerging Economies Present Significant Growth Opportunities
5.2.3.2 Applications of Oxidative Stress Measurement in the Cosmetic Industry
5.3 Porter's Five Forces Analysis
5.3.1 Threat of New Entrants
5.3.2 Threat of Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Degree of Competition
5.4 Supply Chain Analysis
5.5 Value Chain Analysis
5.6 Ecosystem Analysis of the Oxidative Stress Assays Market
5.7 COVID-19 Impact Analysis

6 Oxidative Stress Assays Market, by Product & Service
6.1 Introduction
6.2 Consumables
6.2.1 Kits
6.2.1.1 Kits Accounted for the Largest Share of the Oxidative Stress Assays Market
6.2.2 Reagents
6.2.2.1 Antibodies are the Most Widely Used Reagents in Oxidative Stress Assays
6.3 Instruments
6.3.1 Instruments Segment to Witness Lower Growth Than the Consumables Segment
6.4 Services
6.4.1 Services Segment to Account for a Low Share of the Market During the Forecast Period

7 Oxidative Stress Assays Market, by Technology
7.1 Introduction
7.2 Elisa
7.2.1 Elisa Segment to Dominate the Market During the Forecast Period
7.3 Flow Cytometry
7.3.1 Flow Cytometry is Useful for the Measurement of Cellular Oxidative Stress
7.4 Chromatography
7.4.1 Gas Chromatography is the Preferred Method for the Analysis of Hne
7.5 Microscopy
7.5.1 Digital Microscopes with Advanced Features are Used to Evaluate Oxidative Stress
7.6 High-Content Screening
7.6.1 Hcs is an Emerging Technology in the Oxidative Stress Assays Market
7.7 Label-Free Detection
7.7.1 Label-Free Detection Segment to Witness the Highest Growth During the Forecast Period

8 Oxidative Stress Assays Market, by Test Type
8.1 Introduction
8.2 Indirect Assays
8.2.1 Protein-Based Assays
8.2.1.1 Protein-Based Assays Accounted for the Largest Share of the Indirect Assays Market
8.2.2 Lipid-Based Assays
8.2.2.1 The Most Commonly Used Lipid Peroxidation Assays are Mda Assays
8.2.3 Nucleic Acid-Based Assays
8.2.3.1 Nucleic Acid-Based Assays Accounted for the Lowest Share of the Indirect Assays Market
8.3 Antioxidant Capacity Assays
8.3.1 Glutathione Assays
8.3.1.1 Glutathione Assays Accounted for the Largest Share of the Antioxidant Capacity Assays Market
8.3.2 Ascorbic Acid Assays
8.3.2.1 Ascorbic Acid Assay Kits are Based on Frasc Chemistry
8.3.3 Cell-Based Exogenous Antioxidant Assays
8.3.3.1 These Assays are Used for Measuring the Activity of an Exogenous Antioxidant Compound Within Adherent Cells
8.4 Enzyme-Based Assays
8.4.1 Catalase Activity Assays and Sod Assays are the Two Types of Enzyme-Based Assays Available in the Market
8.5 Reactive Oxygen Species-Based Assays
8.5.1 Ros Assay Kits Measure the Activity of Hydroxyl, Peroxyl, and Other Reactive Oxygen Species

9 Oxidative Stress Assays Market, by Disease Type
9.1 Introduction
9.2 Cardiovascular Diseases
9.2.1 High Prevalence of Cardiovascular Diseases Will Drive Market Growth
9.3 Cancer
9.3.1 Rising Incidence of Cancer to Drive Market Growth
9.4 Diabetes
9.4.1 High and Growing Prevalence of Diabetes to Boost Market Growth
9.5 Respiratory Diseases
9.5.1 Rising Prevalence of Copd to Boost Market Growth
9.6 Other Diseases

10 Oxidative Stress Assays Market, by End-user
10.1 Introduction
10.2 Pharmaceutical and Biotechnology Companies
10.2.1 Pharmaceutical and Biotechnology Companies are the Largest End-users of Oxidative Stress Assays
10.3 Academic Research Institutes
10.3.1 Strengthening of Drug Discovery Research Programs to Drive Market Growth
10.4 Clinical Laboratories
10.4.1 Oxidative Stress Assays are Used in Preclinical Biological Testing
10.5 Contract Research Organizations
10.5.1 Outsourcing of Pharmaceutical R&D Activities to Drive Market Growth
10.6 Cosmetic Industry
10.6.1 Adoption of Oxidative Stress Assays is Expected to Increase in the Cosmetic Industry

11 Oxidative Stress Assays Market, by Region
11.1 Introduction
11.2 North America
11.3 Europe
11.4 Asia-Pacific
11.5 Rest of the World

12 Competitive Landscape
12.1 Overview
12.2 Market Share Analysis
12.2.1 Introduction
12.3 Company Evaluation Matrix
12.3.1 Stars
12.3.2 Emerging Leaders
12.3.3 Pervasive Players
12.3.4 Participants
12.4 Competitive Situations and Trends
12.4.1 Key Partnerships, Agreements, and Collaborations (2017-2020)
12.4.2 Key Product Launches (2017-2020)
12.4.3 Key Acquisitions (2017-2020)
12.4.4 Key Expansions (2017-2020)

13 Company Profiles
13.1 Major Players
13.1.1 Abcam plc
13.1.2 Enzo Biochem, Inc.
13.1.3 Merck KGaA
13.1.4 Qiagen N.V.
13.1.5 Thermo Fisher Scientific, Inc.
13.1.6 Ams Biotechnology (Europe) Ltd.
13.1.7 Biovision, Inc.
13.1.8 Cell Biolabs, Inc.
13.1.9 Oxford Biomedical Research
13.1.10 Cayman Chemical
13.2 Other Players
13.2.1 Eagle Biosciences, Inc.
13.2.2 Arbor Assays
13.2.3 Hycult Biotech
13.2.4 Kamiya Biomedical Company
13.2.5 Mega Tip San.Tic.Ltd.Sti.
13.2.6 Promega Corporation
13.2.7 Callegari Srl
13.2.8 Immunochemistry Technologies, LLC
13.2.9 Genox Corporation
13.2.10 Toxys B.V.

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: The Subscription Portal
14.3 Available Customizations

For more information about this report visit https://www.researchandmarkets.com/r/3vje0y

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets